Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

OX40 Ligand/TNFSF4, Human anti-Human, PE-Atto594, Clone: R4930 (Oxelumab), Novus Biologicals™

Human Monoclonal Antibody

Manufacturer:  Novus Biologicals NBP275913PEATT594100UL

Catalog No. NB009332

This item has been discontinued and is no longer available. Please call customer service for assistance: 1-800-766-7000.


Description

Description

OX40 Ligand/TNFSF4 Monoclonal antibody specifically detects OX40 Ligand/TNFSF4 in Human Samples. It is validated for Flow Cytometry.
Specifications

Specifications

OX40 Ligand/TNFSF4
Monoclonal
PE/ATTO 594
PBS
TNFSF4
Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
100 μL
Cancer, Cell Cycle and Replication, Immunology
7292
Human
Purified
Flow Cytometry
R4930 (Oxelumab)
Flow Cytometry
CD134 ligand, CD134L, CD252, CD252 antigen, Glycoprotein Gp34, gp34, OX40 antigen ligand, OX40 ligand, OX40L, OX-40L, OX4OL, TAX transcriptionally-activated glycoprotein 1, tax-transcriptionally activated glycoprotein 1 (34kD), tax-transcriptionally activated glycoprotein 1, 34kD, tumor necrosis factor (ligand) superfamily, member 4, tumor necrosis factor ligand superfamily member 4, TXGP1
Human
Protein A purified
RUO
Primary
Binds to human OX40L.
Store at 4°C in the dark. Do not freeze.
IgG1 κ
SDS
Documents
Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit